Company: BioNTech AG

Seminars:

3:00 pm Panel Discussion: Exploring the Bestin- Class Adjuvant to Improve Patient Response to Neoantigen Therapy

Seminar_day: Day Three Track A AM

2:30 pm Overcoming Challenges for Effective Cancer Vaccine Therapy

Seminar_day: Day Three Track A AM